Author + information
- Received August 16, 2011
- Revision received October 28, 2011
- Accepted November 1, 2011
- Published online December 13, 2011.
- Aboli A. Rane, MS and
- Karen L. Christman, PhD⁎ ()
- ↵⁎Reprint requests and correspondence:
Dr. Karen L. Christman, Department of Bioengineering, University of California, San Diego, 9500 Gilman Drive, MC 0412, La Jolla, California 92093
The first review on biomaterials for the treatment of myocardial infarction (MI) was written in 2006. In the last 5 years, the general approaches for biomaterial treatment of MI and subsequent left ventricular remodeling remain the same, namely, left ventricular restraints, epicardial patches, and injectable therapies. Nonetheless, there have been significant developments in this field, including advancement of biomaterial therapies to large animal pre-clinical studies and, more recently, to clinical trials. This review focuses on the progress made in the field of cardiac biomaterial treatments for MI over the last 5 years.
- cardiac patch
- left ventricular remodeling
- left ventricular restraint
- myocardial infarction
Ms. Rane has reported that she has no relationships relevant to the contents of this paper to disclose. Dr. Christman is the cofounder of Ventrix Inc. D. Geoffrey Vince, PhD, served as the Guest Editor for this paper.
- Received August 16, 2011.
- Revision received October 28, 2011.
- Accepted November 1, 2011.
- American College of Cardiology Foundation